Kruss; Bernd

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kruss; Bernd.The latest application filed is for "highly concentrated stable meloxicam solutions".

Company Profile

0.6.11

Kruss; Bernd - Hochdorf N/A DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Highly concentrated stable meloxicam solutions Grant 9,993,557 - Henke , et al. June 12, 2	2018-06-12
Highly concentrated stable meloxicam solutions Grant 9,956,288 - Henke , et al. May 1, 2	2018-05-01
Highly Concentrated Stable Meloxicam Solutions App 20170035885 - Henke; Stefan ; et al.	2017-02-09
Highly Concentrated Stable Meloxicam Solutions App 20130178467 - Henke; Stefan ; et al.	2013-07-11
Pharmaceutical composition for intranasal administration containing a CGRP antagonist App 20060193786 - Kruss; Bernd ; et al.	2006-08-31
Highly concentrated stable meloxicam solutions App 20060079516 - Henke; Stefan ; et al.	2006-04-13
Tolerance of 4-(4-(2-pyrrolycarbonyl)-1-piperazinyl)-3-trifluoromethyl-benzoylguanidin- e in intravenous administration App 20060035862 - Votteler; Christine ; et al.	2006-02-16
Tolerance of 4-(4-(2-pyrrolylcarbonyl)-1-piperazinyl)-3-trifluoromethyl-benzoylguanidi- ne in intravenous administration Grant 6,982,256 - Votteler , et al. January 3, 2	2006-01-03
Formulation for the parenteral application of a sodium channel blocker Grant 6,828,311 - Kruss , et al. December 7, 2	2004-12-07
Pharmaceutical composition for intranasal administration containing a CGRP antagonist App 20040076587 - Kruss, Bernd ; et al.	2004-04-22
Formulation for the parenteral application of a sodium channel blocker App 20040019013 - Kruss, Bernd ; et al.	2004-01-29
New formulation for the parenteral application of crobenetine App 20040019075 - Kruss, Bernd	2004-01-29
Tolerance of 4-(4-(2-pyrrolylcarbonyl)-1-piperazinyl)-3-trifluoromethyl-be- nzoylguanidine in intravenous administration App 20030069207 - Votteler, Christine ; et al.	2003-04-10
Highly concentrated stable meloxicam solutions App 20020035107 - Henke, Stefan ; et al.	2002-03-21
Pharmaceutical nanosuspensions for medicament administration as systems with increased saturation solubility and rate of solution Grant 5,858,410 - Muller , et al. January 12, 1	1999-01-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.